BPDZ 154 activates adenosine 5′-triphosphate-sensitive potassium channels: In vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 4860-4868

  Cosgrove, Karen E ^{a,b,c,d,e,f,g,h}   Antoine, Marie Hélène ^{a,b,c,d,e,f,g,h}   Lee, Anne T ^{a,b,c,d,e,f,g,h}   Barnes, Philippa D ^{a,b,c,d,e,f,g,h}   De Tullio, Pascale ^{a,b,c,d,e,f,g,h}   Clayton, Peter ^{a,b,c,d,e,f,g,h}   McCloy, Rory ^{a,b,c,d,e,f,g,h}   De Lonlay, Pascal ^{a,b,c,d,e,f,g,h}   Nihoul Fékété, Claire ^{a,b,c,d,e,f,g,h}   Robert, Jean Jacques ^{a,b,c,d,e,f,g,h}   Saudubray, Jean Marie ^{a,b,c,d,e,f,g,h}   Rahier, Jacques ^{a,b,c,d,e,f,g,h}   Lindley, Keith J ^{a,b,c,d,e,f,g,h}   Hussain, Khalid ^{a,b,c,d,e,f,g,h}   Aynsley Green, Al ^{a,b,c,d,e,f,g,h}   Pirotte, Bernard ^{a,b,c,d,e,f,g,h}   Lebrun, Philippe ^{a,b,c,d,e,f,g,h}   Dunne, Mark J ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DICHLORO 3 ISOPROPYLAMINO 4H 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; ADENOSINE TRIPHOSPHATE; BPDZ 154; CALCIUM 45; DIAZOXIDE; EFAROXAN; GLIBENCLAMIDE; GLUCOSE; IMIDAZOLINE; INSULIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; RUBIDIUM 86; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; HYPERINSULINISM; INFANT; INSULIN RELEASE; INSULINOMA; ION TRANSPORT; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZOFURANS; BENZOTHIADIAZINES; CALCIUM RADIOISOTOPES; CELL LINE; CHILD, PRESCHOOL; CYCLIC S-OXIDES; FEMALE; GLUCOSE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; IMIDAZOLES; INFANT; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; MALE; PANCREATIC NEOPLASMS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RUBIDIUM RADIOISOTOPES; TOLBUTAMIDE;

ANIMALIA; RODENTIA;

EID: 0036846468     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020439     Document Type: Article

References (46)

1. Glaser B, Thornton PS, Otonkoski T, Junien C 2000 The genetics of neonatal hyperinsulinism. Arch Dis Child 82:79-86
2. Sempoux C, Guiot Y, Lefevre A, Nihoul-Fekete C, Jaubert F, Saudubray JM, Rahier J 1998 Neonatal hyperinsulinemic hypoglycemia: Heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 83:1455-1461
3. de Lonlay-Debeney P, Poggi-Trovert F, Fournet JC, Sempoux J, Vici AD, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fékété C, Robert JJ, Saudubray JM 1999 Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 340:1169-1175
4. de Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, Delagne V, Mayaud C, Chigot V, Sempoux C, Brusset MC, Laborde K, Bellane-Chantelot C, Vassault A, Rahier J, Junien C, Brunelle F, Nihoul-Fekete C, Saudubray JM, Robert JJ 2002 Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 161:37-48
5. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 1997 Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycaemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100:802-807
6. Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 1998 Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 102:1286-1291
7. Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 2001 Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozy-gosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 158:2177-2184
8. Glaser B, Furth J, Stanley CA, Baker L, Thornton PA, Landau H, Permutt MA 1999 Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism. Hum Mutat 14:23-29
9. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230
10. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M 1998 Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352-1357
11. Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE 2001 Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J Clin Invest 108:457-465
12. ATP channels in β-cells causes persistem hyperinsulinaemic hypoglycaemia of infancy. Nat Med 2:1344-1347
13. Dunne MJ, Kane C, Shepherd RM, Sanchez G, James RFL, Johnson PRV, Aynsley-Green A, Lu S, Clement JP, Lindley KJ, Seino S, Aguilar-Bryan L 1997 Familial persistent hyperinsulinemic hypoglycaemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703-706
14. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fékété C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P, Lindley JK 2000 The practical management of hyperinsulinism in infancy. Arch Dis Child 82:F98-F107
15. Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, Saudubray JM 1998 Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: A retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 157:628-633
16. Sadeghi-Nejad A, Graeme-Cook FM 2001 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2001. A newborn girl with seizures and persistent hypoglycaemia. N Engl J Med 345:1833-1839
17. + channels and inhibiting insulin release. Diabetologia 43:723-732
18. Boverie S, Antoine MH, de Tullio P, Somers F, Becker B, Sebille S, Lebrun P, Pirotte B 2001 Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1, 2, 4-benzothiadiazine 1, 1-dioxide (BPDZ 73): Introduction of heteroatoms on the 3-alkylamino side chain of Lhe benzothiadiazme 1, 1-dioxide ring. J Pharm Pharmacol 53:973-980
19. + channels. Biochem Pharmacol 47:1381-1386
20. Antoine MH, Pirotte B, Hermann M, de Tullio P, Delarge J, Herchuelz A, Lebrun P 1994 Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets. Experientia 50:830-832
21. 2+ influx into pancreatic B cell. Am J Physiol 242:E56-E66
22. + channels and inhibition of insulin release: Effect of BPDZ 62. J Pharmacol Exp Ther 277:156-162
23. + channels in endocrine and smooth muscle tissues. Br J Pharmacol 134:375-385
24. Leclercq-Meyer V, Marchand J, Woussen-Colle M-C, Giroix M-H, Malaisse WJ 1985 Multiple effects of leucine on glucagon, insulin and somatostatin secretion from the perfused rat pancreas. Endocrinology 116:1168-1174
25. ATP channel-independent pathways. Diabetes 50: 329 -339
26. Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd RM, Giesberts AN, White SJ, Ämmälä C, Flatt PR, Dunne MJ 1999 ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 β-cell line. Diabetes 48:2349-2357
27. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ 1981 Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100
28. + channels in an insulin-secreting cell line. J Membr Biol 99:215-224
29. De Tullio P, Pirotte B, Somers F, Boverie S, Lacan F, Delarge J 1998 Study of the ring closure reaction of o-aminoarylsulfonamides with 1, 1′-thiocarbonyldiimidazole. Tetrahedron 54:4935-4942
30. Raffa L, Di Bella M, Ferrari P, Rinaldi M, Ferrari W 1974 Cardiovascular effect of the 1, 2, 4-benzothia diazine-1, 1-dioxide. IV Farmaco 29:411-423
31. Bitner-Glindzicz M, Lindley KJ, Rutland P, Blaydon D, Smith VV, Milla PJ, Hussain K, Furth-Lavi J, Cosgrove KE, Shepherd RM, Barnes PD, O'Brien RE, Farndon PA, Liu X, Sowden J, Malcolm S, Dunne MJ, Aynsley-Green A, Glaser B 2000 A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher Type 1C gene. Nat Genet 26:56-60
32. Lawson K, Dunne MJ 2001 Peripheral channelopathies as targets for potassium channel openers. Expert Opin Investig Drugs 10:1345-1359
33. Cosgrove KE, Barnes PD, O'Brien RE, Rahier J, Fournet J-C, Junien C, Nihoul-Fekete C, Swift SM, Lindley KJ, Glaser B, Saudubray J-M, Aynsley-Green A, Dunne MJ 2001 Typing hyperinsulinism of infancy from a cohort of 68 patients. Pediatr Res 49:44A
34. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement 4th JP, Gonzalez G, Aguilar-Bryan L, Permutt MA, Bryan J 1996 Adenosine diphosphate as ah intracellular regulator of insulin secretion. Science 272:1785-1787
35. Otonkoski T, Ammälä C, Huopio H, Cote GJ, Chapman JC, Cosgrove KE, Ashfield R, Huang E, Komulainen J, Ashcroft FM, Dunne MJ, Kere J, Thomas PM 1999 A point mutation inactivating Lhe sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycaemia of infancy in Finland. Diabetes 48:408-415
36. ATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycaemia of infancy. Proc Natl Acad Sci USA 98:2882-2887
37. Zucker LM, Antoniades HN 1972 Insulin and obesity in the Zucker genetically obese rat "fatty." Endocrinology 90:1320-1330
38. Alemzadeh R., Slonim AE, Zadnowicz MM, Maturo J 1993 Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133:705-712
39. Alemzadeh R, Jacobs W, Pitukcheewanont P 1996 Anti-obesity effect of diazoxide in obese Zucker rats. Metabolism 45:334-351
40. Hensley IE, Lawler JE, Alemzadeh R, Holshouser SJ 2001 Diazoxide effects on hypothalamic and extra-hypothalamic NPY content in Zucker rats. Peptides 22:899-908
41. Rasmussen SB, Sorensen TS, Hansen JB, Mandrup-Poulsen T, Hornum L, Markholst H 2000 Functional rest through intensive treatment with insulto and potassium channel openers preserves residual β-cell function and mass in acutely diabetic BB rats. Horm Metab Res 32:294-300
42. Greenwood RH, Mahler RF, Hales CN 1976 Improvement in insulin secretion in diabetes after diazoxide. Lancet 1:444-447
43. Bjork E, Berne C, Kampe O, Wibell L, Oskarsson P, Karlsson FA 1996 Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45:1427-1430
44. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE 1998 Beneficiai effect of diazoxide in obese hyperinsulinernic adults. J Clin Endocrinal Metab 83:1911-1915
45. Leahy JL, Bumbalo LM, Chen C 1994 Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43: 173-179
46. Wahl P, Dabrowski M, Boonen H, Olsen HR, Kofod H, Bondo-Hansen J 2002 A novel diazoxide analogue selectively activates SUR1/Kir6.2 channels. Diabetes 50:A352-A353